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PannexinsPannexin 1 (Panx1) is involved in endothelium-dependent vasodilation in large arteries, but the
exact mechanistic role remains poorly understood. We hypothesized that Panx1 facilitates large
vessel relaxations regulating endothelium-derived hyperpolarization (EDH)-like mechanisms. The
EDH-like component of acetylcholine-induced relaxation of saphenous arteries studied in isometric
myograph after inhibition of NO-synthase and cyclooxygenase was signiﬁcantly impaired in mice
with genetically ablated Panx1 (KO) relative to that in the wild type (WT) mice. Application of
P1-receptor antagonist and apyrase signiﬁcantly reduced this component in WT, but not in KO mice,
indicating participation of ATP released via Panx1 in the EDH-like relaxation.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Recently characterized membrane channel proteins pannexins
were shown to participate in numerous physiological and
pathological processes [18]. Pannexin family has three members:
Panx1, Panx2 and Panx3. Panx1 is represented ubiquitously in
mammalian tissues, including brain, heart, skeletal muscles and
vasculature. In murine vasculature, the pattern of Panx1 expres-
sion and its impact on vascular function depend on the vessel size.
Panx1 is abundant in the smooth muscle cells in smaller arteries
and arterioles [14]. In such arteries the release of ATP via Panx1
hemichannels was shown to be involved in the incrementalcontractile response during adrenoceptor activation [1].
Conversely, we have shown that in the saphenous artery (a larger
resistance-type vessel) Panx1 is expressed predominantly in the
endothelium and Panx1/ mice lacking this channel have signiﬁ-
cantly impaired endothelial function [9]. However, the mechanistic
understanding of the role of Panx1 in endothelium-dependent
relaxation remains to be uncovered.
Currently, three main pathways of endothelium-dependent
relaxation are characterized, including those mediated by nitric
oxide (NO), prostacyclin (PGI2) and endothelium-derived
hyperpolarization (EDH). In contrast to well-deﬁned NO and PGI2
pathways, the molecular constituents of the EDH mechanism
remain controversial. Initially it was described as a factor respon-
sible for smooth muscle hyperpolarization independent of NO or
prostacyclin [7]. Currently, a number of diverse factors are sug-
gested to play a role in EDH, including K+, H2O2 and adenosine
among them [7,16]. However, regardless of these speciﬁcs, the ini-
tial step of EDH is the hyperpolarization of endothelial cells follow-
ing the activation of speciﬁc for endothelial cells intermediate
(IKCa) and small conductance (SKCa) calcium-activated potassium
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cells, thus leading to relaxation. The inﬂuence of EDH-like
mechanisms on the arterial dilation can, therefore, be evaluated
by the blockade of IKCa and SKCa channels.
In this study we focused on the role of Panx1 in EDH
mechanisms for the following reasons. First, pannexins are known
to form ATP-permeable hemichannels [4,18]. ATP released from
endothelial cells can cause vasorelaxation in an EDH-like manner
[12]. In addition, ectonucleotidases may hydrolyze ATP to adeno-
sine, the latter demonstrating EDH-like effects in human coronary
arteries [16]. Finally, hyperpolarization signal may be conducted
from endothelial to smooth muscle cells via myoendothelial gap
junctions [5,7]. Notably, pannexins were shown to form functional
gap junctions in some cell types [2,11,20,22]. Therefore, it is feasi-
ble to suggest that Panx1-formed hemichannels or gap junctions
can participate in the EDH-like relaxation. We therefore hypothe-
sized, that Panx1 facilitates endothelium-dependent relaxations
via regulation of one or several EDH-mechanisms.
2. Materials and methods
2.1. Animals
The Panx1/ mouse strain was described previously [6]. All
experiments in this study were performed in full compliance with
the NIH Guide for the Care and Use of Laboratory Animals and
Russian national guidelines for animal research. The protocols
were approved by the University of Miami IACUC (protocol #12-
051) and Institute for Information Transmission Problems,
Russian Academy of Sciences IACUC (protocol #02-2013). Wild
type (WT) animals were age-matched (2-3 months old) male mice
of the C57BL/6 background. Mice were housed under standard con-
ditions of temperature and humidity, with a 12-h light/dark cycle
and free access to food and water.
2.2. Wire myography
We studied the responses of the saphenous artery for which it
was previously shown that its relaxation caused by ACh is partially
dependent on EDH-mechanisms [10]. For force recording, 2-mm
arterial ring preparations were isolated and mounted in wire myo-
graph (DMT, Denmark, Model 620 M). Physiological salt solution
contained (in mM): 120 NaCl, 26 NaHCO, 4.5 KCl, 1.6 CaCl2, 1
MgSO4, 1.2 NaH2PO4, 5.5 D-glucose, 0.025 EDTA and 5 HEPES was
used throughout the experiment. The vessels were stretched to
an internal circumference at which they developed maximal active
tension [15] and kept at 37 C, bubbled with a gas mixture (95% O2,
5% CO2) for maintaining pH 7.4. Arteries were activated 2 times
with 10 lM norepinephrine and the functional activity of the
endothelium was checked subsequently using 10 lM acetylcholine
(ACh) during 1–3 lM norepinephrine-induced precontraction.
Endothelium-dependent relaxation was studied during cumulative
addition of ACh in rising concentrations from 0.01 lM to 10 lM
after phenylephrine-induced precontraction that averaged 60% of
maximal vessel response to norepinephrine. Such level of precon-
traction was achieved with phenylephrine concentrations ranged
from 0.3 lM to 1 lM in both WT and Panx1/ animals.
2.3. Gene expression
Gene expression levels were measured by quantitative PCR,
performed in Rotor Gene 6000 (Corbett Research, Australia) with
SYBR Green master mix (Syntol, Russia) and the following proto-
col: 95 C for 10 min, followed by 40 cycles, consisting of three
phases: 30 s at 95 C, 30 s at 62 C (for Panx2) or 60 C (for
Panx3, Cx43, Cx40 and Cx45) or 64 C (for Cx37 and GAPDH) and60 s at 72 C. Primer sequences (50-30) for Panx2: forward TCACC
AAGAACTTCGCAGAGGA, reverse GGAAGTTGAGCTCCGAGGTGA;
for Panx3: forward CAGGAGTTCTCATCAGGGTCT, reverse AGAGA
GTAGGGAAGAGCCTTGT; for connexin 37: forward CGGGCAAGCA
GGCGAGAGAG, reverse CCGGCTGGGCTGTGTTACACT; for connexin
43: forward CACTTTCATTAAGTGAAAGAGAGGT, reverse GGGTTGTT
GAGTGTTACAGCGA; for GAPDH (reference gene): forward ATGGA
GAAGGCCGGGGCCCA, reverse GATGGCATGGACTGTGGTCATG; for
connexin 40: forward GGAGGAGGAAAGGAAGCAGGTG, reverse
GCCCAGGACCAGCATGCGGA; for connexin 45: forward CAATCG
AGGAACTCAAGAGAGAAT, reverse ATAGCATATCCCAGGTACATCA
CA. To avoid possible ampliﬁcation from genomic DNA, primers
were designed to span the intron and to continue to the adjacent
exon by 3 nucleotides on the 30 prime end.
2.4. Immunohistochemistry
After transluminal perfusion by 4% paraformaldehyde in PBS
and saphenous arteries were dissected, cleaned from adjacent
tissues and cut into 0.5–1.0 mm long segments. Staining was
performed in whole mounts. In brief, the segments were permeabi-
lized by 0.5% Triton X-100 in PBS for 1 h and incubated in blocking
buffer with 5% rabbit serum, 5% BSA, 0.3% Triton X-100 in PBS for
3 h with shaking at room temperature. Staining with primary
anti-mouse Panx1 CT-395 antibodies ([17]; 1:800 dilution) was
performed at room temperature in blocking solution overnight
with shaking to ensure luminal penetration of antibodies. After
washing, secondary goat anti-rabbit Alexa-546 conjugated
antibodies were added and incubated overnight in the same condi-
tions. After washing and incubation with DAPI, arterial segments
were mounted on slides, coverslipped without longitudinal cutting
(resulting in ﬂattened samples) and imaged at Leica SP5 confocal
microscope using 40 objective.
2.5. Drugs
Acetylcholine, phenylephrine, 8-(p-sulfophenyl)-theophylline
(8-SPT; 100 lM), apyrase (10 U/ml), carbenoxolone (100 lM),
BaCl2 (30 lM), indomethacin (10 lM) and TRAM-34 (1 lM) were
obtained from Sigma. L-NNA (100 lM) was obtained from Alexis
Biochemicals, UCL-1684 (0.1 lM) from Tocris and ouabain
(10 lM) from MP Biomedicals. The numbers in brackets show the
concentrations of substances used in the experiments.
2.6. Statistical analysis
All data are expressed as means ± S.E.M.; n represents the
number of animals tested. The differences between concentration–
response relationships to ACh were evaluated using Repeated
Measures ANOVA, followed by Bonferroni correction for repeated
measurements to deﬁne the effects of inhibitors at certain ACh
concentrations. In addition, individual concentration–response
relationships were ﬁtted to a sigmoidal dose–response with vari-
able slope using GraphPad Prizm 5.0 Software (La Jolla, CA, USA)
for calculation of pD2 (the negative logarithm of the EC50 value)
and Emax (maximal response value). Statistically signiﬁcant differ-
ences for pD2 and maximal response values, as well as for relative
mRNA expression were determined using unpaired Student’s
t-test. Statistical signiﬁcance was reached at P < 0.05.
3. Results
3.1. EDH-like component of relaxation is impaired in Panx1/ mice
In line with our previous ﬁndings [9], endothelium-dependent
relaxations to ACh were impaired in arteries of Panx1/ mice in
Fig. 1. Concentration–response relationships to ACh in saphenous arteries fromWT
and Panx1/ mice. ⁄P < 0.05. Numbers in brackets indicate the number of
experiments. Error bars for some points are smaller than the symbols.
1166 D. Gaynullina et al. / FEBS Letters 589 (2015) 1164–1170comparison to WT animals (Fig. 1 and Table 1). We showed as well
that Panx1 mRNA localizes predominantly to endothelial cells of
the murine saphenous artery [9]. The presence of Panx1 in
endothelium was also conﬁrmed by immunohistochemistry in
saphenous artery whole mounts (Fig. 2). The Panx1-speciﬁc stain-
ing was absent in similar preparations from Panx1/ arteries
(Fig. 2). Importantly, genetic ablation of Panx1 did not cause com-
pensatory up-regulation of Panx2 or Panx3 expression in saphe-
nous arteries. Panx2 and Panx3 mRNAs were not found by
quantitative PCR in saphenous arteries of either WT or Panx1/
mice although they were detected in murine brain samples
(Panx2) and cartilaginous tissue samples from the ear auricle
(Panx3), validating primer functionality.
Next, to explore the role of Panx1 in the endothelium-depen-
dent relaxation, we compared the effects of the combined inhibi-
tion of NO and PGI2 synthesis in WT and Panx1/ mice.
Treatment of the arteries with L-NNA and indomethacin, NO-syn-
thase and cyclooxygenase inhibitors, respectively, has revealed
that the combined contribution of NO and PGI2 to ACh-induced
relaxation was greater in Panx1/ as compared to WT mice
(Fig. 3A,B and Table 1).
The part of ACh-induced relaxation resistant to inhibition of NO
and PGI2 synthesis reﬂects the contribution of EDH-like mecha-
nisms to the endothelium-dependent relaxation. To compare these
components in the Panx1/ and WTmice, we utilized the blockers
of endothelial IKCa and SKCa, channels TRAM-34 and UCL-1684,
respectively. The combined blockade of IKCa and SKCa in the pres-
ence of L-NNA and indomethacin further reduced ACh-induced
relaxations in both WT and Panx1/ mice (Fig. 3A,B and
Table 1). Intriguingly, the portion of the ACh-induced relaxation
blocked by the combination of TRAM-34 and UCL-1684 was signiﬁ-
cantly larger in the arteries of WT vs. Panx1/mice (Fig. 3A and B).Table 1
pD2 (the negative logarithm of the EC50) and Emax (maximal response) values for ACh fo
presence of inhibitors.
WT
pD2
Control (in the absence of inhibitors) 7.28 ± 0.09
TRAM-34 + UCL-1684 6.83 ± 0.20⁄
L-NNA + Indo 7.22 ± 0.05
L-NNA + Indo + TRAM-34 + UCL-1684 6.05 ± 0.21#
L-NNA + Indo + 8-SPT 6.60 ± 0.13#
L-NNA + Indo + 8-SPT + Apyrase 6.09 ± 0.10@
L-NNA + Indo + Ba2+ + Ouabain 6.00 ± 0.13#
L-NNA + Indo + Ba2+ + Ouabain + Carb 6.67 ± 0.05$
Indo – indometacine; Carb – carbenoxolone. &P < 0.05 vs.WT under control conditions; ⁄v
group: @vs. L-NNA + Indo + 8-SPT in the respective animal group; $vs L-NNA + Indo + BaCombined, these data indicate that the EDH-like mechanism in
ACh-induced relaxation is impaired in the absence of Panx1.
These conclusions were supported by the experiments, studying
the effects of IKCa and SKCa blockers in the absence of NO-synthase
and cyclooxygenase inhibitors. The sensitivity of saphenous artery
to ACh (pD2 value) was signiﬁcantly reduced by the blockade of
IKCa and SKCa channels in WT (Fig. 3C and Table 1), but not in
Panx1/ mice (Fig. 3D and Table 1). Altogether, these results
demonstrate that the ablation of Panx1 causes signiﬁcant reduc-
tion of the EDH-like component of endothelium-dependent relax-
ation in the murine saphenous artery.
3.2. Panx1-mediated purinergic signaling underlies the EDH-like
mechanism of endothelium-dependent relaxation
The role Panx1 plays in the regulation of the EDH-like compo-
nent of endothelium-dependent relaxation raises the question
about the underlying molecular mechanism(s). Extracellular ATP
released via Panx1 may affect vascular tone directly or indirectly,
by conversion into adenosine executed by cell surface ecto-
ATPases. Adenosine activates P1-receptors on the vascular wall
and leads to vasodilation in an EDH-like manner [16]. To examine
the involvement of P1 receptors, we tested their blocker 8-SPT in
the presence of L-NNA + indomethacin in arteries of WT (Fig. 4A,
blue line) and Panx1/ (Fig. 4B, blue line) mice. The blockade of
the P1 receptors slightly decreased the sensitivity for ACh in WT
arteries, as indicated by reduced pD2 value (Table 1), but did not
change the sensitivity for ACh in Panx1/ vessels (Table 1).
The ACh-induced endothelium-dependent relaxation was
reported to be partially associated with the activation of P2Y
receptors on endothelial cells by ATP, which provokes the EDH-like
relaxation of arteries [12]. Given the large diversity of purinergic
receptor subtypes [3] and the lack of truly selective inhibitors for
many of them, we tested P2 receptor involvement by depleting
extracellular ATP with an externally added apyrase enzyme in
the presence of P1 receptors blocker. Apyrase treatment in the
presence of 8-SPT + L-NNA + indomethacin signiﬁcantly impaired
the endothelium-dependent relaxations of WT arteries (Fig. 4A)
by reducing both pD2 and Emax (Table 1), but didn’t alter the relax-
atory responses of Panx1/ arteries (Fig. 4B and Table 1).
Therefore, the combined treatment with apyrase and P1-receptor
blocker considerably decreases the EDH-like component of ACh-in-
duced relaxation in WT but not Panx1/ animals.
3.3. The effects of EDH-blockade at the smooth muscle level are
reduced in Panx1/ arteries
To cause vasodilation, the hyperpolarization originating in
endothelial cells has to be transmitted to the smooth muscles.r saphenous arteries of WT and Panx1/ mice under control conditions and in the
Panx1/
Emax pD2 Emax
97 ± 2 7.12 ± 0.09 85 ± 7&
95 ± 1 7.17 ± 0.06 86 ± 5
65 ± 10⁄ 6.78 ± 0.11⁄ 39 ± 3⁄
14 ± 6# 6.26 ± 0.23 26 ± 8
74 ± 7 6.63 ± 0.25 30 ± 11
42 ± 7@ 6.34 ± 0.20 28 ± 6
53 ± 12 6.20 ± 0.08# 19 ± 12
22 ± 10$ 6.08 ± 0.09 18 ± 7
s. control in the respective animal group; #vs. L-NNA + Indo in the respective animal
2++Ouabain in the respective animal group.
Fig. 2. Panx1 is observed immunohistochemically in the endothelium of saphenous artery in WT mice. Confocal images of merged Z-stacks scanned along the border of
endothelium layer fold in a ﬂattened whole mount preparation co-labeled for Panx1 (red) and nucleic acids with DAPI (blue). Autoﬂuorescence of internal elastic lamina (IEL)
is shown in green. The thickness of the analyzed section is 5 micron. Punctate Panx1 labeling is abundant in WT arteries and co-localizes with IEL autoﬂuorescence and
vertically oriented elliptic-shaped nuclei of endothelial cells. Labeling outside of this region (right side where round-shaped transverse sections of smooth muscle cell nuclei
are observed) is signiﬁcantly reduced. Speciﬁc Panx1 labeling is not detected in Panx1/ arteries. Scale bar: 5 lm.
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release of K+ from endothelial cells via IKCa channels followed by
the activation of Na+/K+-ATPase and inwardly rectifying potassium
channels (KIR) in the smooth muscles [7,8]. To evaluate the role of
this conventional mechanism in EDH-like signal transmission we
used ouabain and Ba2+, the blockers of Na+/K+-ATPase and KIR,
respectively. In the presence of L-NNA and indomethacin, this
treatment resulted in a signiﬁcant decrease in the relaxatory
responses to ACh in both WT and Panx1/ mice (Fig. 5A and B,
black lines). The respective change in sensitivity to Ach, however,
was smaller in Panx1/ vs. WT mice (Table 1).
In Panx1/ animals the EDH-like component of ACh-induced
relaxation was almost completely abolished by the combined
blockade of Na+/K+-ATPase and KIR. In contrast, the part of EDH-like
component persisted in WT animals under the same conditions
(Fig. 5A and B, black lines). These data suggest the existence of
an additional pathway for the EDH-like signal transmission from
endothelial to smooth muscle cells in the arteries of WT mice, that
is incapacitated in Panx1/ ones. We also observed, that treat-
ment of arteries with the gap junction blocker carbenoxolone in
the presence of ouabain + Ba2+ + L-NNA + indomethacin almost
completely abolished the relaxatory response to ACh in WT mice,
but didn’t change the response of Panx1/ arteries (Fig. 5A,B, blue
lines and Table 1). One way to interpret this result is that gap junc-
tions that transmit the EDH-like signal from endothelial to smooth
muscle cells in WT animals are lacking in Panx1/ mice.
Importantly, the expression levels of connexin 37 and connexin43, the isoforms that form myoendothelial gap junctions in the
murine saphenous artery [19], did not differ between WT and
Panx1/ arteries (Fig. 5C and D). This result excludes the reduced
connexin 37 and 43 expression in Panx1/ mice as a possible
underlying reason for altered EDH-like signal transmission.
Connexin 40 expression levels were not different in WT and
Panx1/ arteries (Fig. 5E) and connexin 45 expression level in
Panx1/ arteries was lower compared to WT arteries (Fig. 5F).
4. Discussion
This study shows that endothelium-dependent relaxation
mechanisms are signiﬁcantly altered in the Panx1/ mice relative
to WT arteries. The EDH-like component of ACh-induced relaxation
is impaired in the absence of Panx1, as seen from reduced effects of
either IKCa and SKCa blockers or blockers of Na+/K+-ATPase and KIR.
The realization of EDH-like component of endothelium-dependent
relaxation in WT saphenous arteries is preferably associated
with the activation of P2-receptors and, to a lesser degree, with
P1-receptors. However, purinergic signaling is greatly suppressed
in Panx1/ arteries, indicating that Panx1-mediated release of
ATP augments the EDH-like component of endothelium-dependent
dilations in saphenous arteries.
Large reduction of EDH-like relaxation in Panx1/ mice was
associated with up-regulation of other dilatory pathways, such as
NO- and PGI2-signaling. The factors and mechanisms, responsible
for compensatory redistribution of endothelial dilatory pathways
Fig. 3. The effect of Panx1 ablation on the EDH-like component of ACh-induced relaxations of saphenous arteries. (A and B) Concentration–response relationships to ACh of
saphenous arteries of WT (A) and Panx1/ (B) mice in the presence of vehicle (control), or L-NNA + indomethacin or TRAM-34 + UCL-1684 + L-NNA + indomethacin. (C and D)
Concentration–response relationships to ACh of saphenous arteries of WT (C) and Panx1/ (D) mice in the presence of vehicle (control), or TRAM-34 + UCL-1684. ⁄P < 0.05.
Number in brackets indicates the number of experiments. Error bars for some points are smaller than the symbols.
Fig. 4. Purinergic signaling via Panx1-formed hemichannels serves as EDH-like mechanism in murine saphenous artery. Concentration–response relationships to ACh of
saphenous arteries of WT (A) and Panx1/ (B) mice in the presence of L-NNA + indomethacin or 8-SPT + L-NNA + indomethacin or apyrase + 8-SPT + L-NNA + indomethacin.
⁄P < 0.05 (repeated measures ANOVA). Number in brackets indicates the number of experiments.
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studies.
Purinergic signaling (including adenosine and ATP) is responsi-
ble for a signiﬁcant portion of the EDH-like response in saphenous
artery, since its inhibition signiﬁcantly suppressed EDH-like relax-
ations in WT animals. Consistent with the Panx1 channel function
as anATP-permeable pore in this pathway, the responsewas smaller
and the blockadewasnot observed in Panx1/mice. The increase of
cytoplasmic Ca2+ concentration in the endothelial cell during ACh
stimulation is probably sufﬁcient to cause Panx1 hemichannel
activation [13], which allows ATP release into extracellular space.
Extracellular ATP can activate P2Y receptors on endothelial cell
surfaces, thereby triggering an additional increase in intracellular
Ca2+ [23] and further potentiating Panx1-hemichannels [13]. Anadditionalmechanism involves adenosine receptor signaling stimu-
lated by the hydrolysis of the released ATP to adenosine that dilates
vessels by binding to P1 receptors. Thus, purinergic signaling via
Panx1-P2Y pathway may serve as a feedforward mechanism of
endothelial activation to provide full realization of EDH-like relax-
ation. A direct contribution of Panx1-dependent calcium inﬂux in
ACh responses is possible as well [22], but the role of this mecha-
nism in mammalian tissues, particularly in the vasculature, has
not been explored yet.
Another argument supporting the proposed role of Panx1 in
full-manifested endothelium-dependent dilation was obtained by
studying the blockade of Na+/K+-ATPase and KIR channels. These
data demonstrates that the effect of the blockade is signiﬁcantly
reduced in the arteries of Panx1/ vs WT mice. The part of
Fig. 5. Panx1 is essential for transmission of EDH-like signal from endothelial to smooth muscle cells. (A and B) Concentration–response relationships to ACh of saphenous
arteries of WT (A) and Panx1/ (B) mice in the presence of L-NNA + indomethacin or L-NNA + indomethacin + Ba2+ + ouabain or L-
NNA + indomethacin + Ba2+ + ouabain + carbenoxolone. ⁄P < 0.05 (repeated measures ANOVA); #P < 0.05 (ANOVA followed by followed by Bonferroni correction for repeated
measurements). (C – F) Relative to GAPDH mRNA expression levels of connexin 37 (C), connexin 43 (D), connexin 40 (E) and connexin 45 (F) in saphenous arteries of WT and
Panx1/ mice. $P < 0.05 (Student’s t-test). Number in brackets indicates the number of experiments.
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sible involvement of gap junctions in mediating signal transduc-
tion from endothelial to smooth muscle cells [8]. The existence
of such alternative mechanism of EDH-like signal transduction
was conﬁrmed in the experiments with gap junction blocker
carbenoxolone, which signiﬁcantly reduced the endothelium-
dependent relaxation in WT, but not in Panx1/ arteries.
Connexins 37 and 43 were previously shown to formmyoendothelial
gap junction in the murine saphenous artery [19]. However,
our analysis showed that the levels of the connexin 37, 40 and
43 gene expression did not differ in saphenous arteries of WT
and Panx1/ animals. Despite the expression level of connexin 45
was reduced in arteries of Panx1/ mice, we assume that this
connexin isoform does not play a role in the EDH-like signal
transduction, because it is expressed in smooth muscle, but not
in endothelial cells [21]. Thus, the difference between the strains
in responses to carbenoxolone may be assigned to the activity of
Panx1. This hypothesis will be tested directly in our future studies.The model summarizing possible involvement of the Panx1
channel in EDH-like mechanisms is shown in Fig. 6. First, ACh
binds to the receptor on endothelial surface, leading to the increase
in cytosolic Ca2+ concentration, which in turn, activates Panx1
hemichannels and causes the release of ATP from the cell.
Extracellular ATP activates P2 receptors or is hydrolyzed to adeno-
sine, which activates P1 receptors. Signaling pathways down-
stream of these receptors cause the additional rise of cytoplasmic
Ca2+ concentration thereby augmenting IKCa and SKCa channels
activation and hyperpolarization of endothelial cell. In our opinion,
this feedforward loop represents the major mechanism of Panx1
involvement in the EDH-response. Under the conditions of full-
manifested endothelial cells activation, the hyperpolarizing signal
is transmitted to neighboring smooth muscle cell by either K+
released through IKCa channels or via myoendothelial gap junc-
tions, formed by connexins and probably by Panx1. Therefore,
Panx1 may facilitate endothelium-dependent arterial relaxation
via regulation of one or two EDH-mechanisms.
Fig. 6. Possible mechanisms of Panx1 involvement in the functioning of EDH-like mechanism during ACh-induced stimulation followed by smooth muscle relaxation. For
further explanation see text. IKCa – endothelial intermediate conductance calcium-activated potassium channels; SKCa – small conductance calcium-activated potassium
channels; R – receptor; ACh – acetylcholine; Ado – adenosine; ER – endoplasmic reticulum; IP3R – 1,4,5-inositol trisphosphate receptor; EC – endothelial cell; IEL – internal
elastic lamina; SMC – smooth muscle cell; MEGJ – myoendothelial gap junctions; GJ – gap junctions; KIR – inwardly rectifying potassium channels.
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